(Q24234881)

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Oral steroids for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

A study of the blood lipoids and blood protein in Canadian Eastern Arctic Eskimos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Current concepts on pulmonary host defense mechanisms in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Omega-3 fatty acids (from fish oils) for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

Effect of marine oils supplementation on coagulation and cellular activation in whole blood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

The use of an intravenous fish oil emulsion enriched with omega-3 fatty acids in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

Nutritional requirements in cystic fibrosis: a review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021

Newly diagnosed cystic fibrosis in middle and later life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002201.PUB3

7 January 2021